Outcome measures and anti-rheumatoid drugs: a critical appraisal
Dixon, J.S.; Wright, V.
Clinical and Experimental Rheumatology 4(1): 1-2
1986
ISSN/ISBN: 0392-856X PMID: 3698357 Document Number: 285928
Document emailed within 1 workday
Related Documents
Jones, J.G. 1995: Interrelationship of outcome measures and process variables in early rheumatoid arthritis Journal of Rheumatology 22(1): 186Veehof, M.M.; ten Klooster, P.M.; Taal, E.; van Riel, P.L.C.M.; van de Laar, M.A.F.J. 2008: Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis Journal of Rheumatology 35(4): 610-617
Pybus, P.K. 1983: Anti-amoebic drugs in rheumatoid arthritis South African Medical Journal 63(2): 31
van Leeuwen, M.A.; van der Heijde, D.M.; van Rijswijk, M.H.; Houtman, P.M.; van Riel, P.L.; van de Putte, L.B.; Limburg, P.C. 1994: Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants Journal of Rheumatology 21(3): 425-429
Kovarsky, J. 1985: Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis Texas Medicine 81(9): 35-39
Dougados, M. 2004: Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis Journal of Rheumatology. Suppl 70: 66-69
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Scott, I.C.; Kingsley, G.H.; Scott, D.L. 2013: Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clinical and Experimental Rheumatology 31(4 Suppl 78: S4-S8
Kurowski, M.; Dunky, A. 1992: Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 479
Boers, M. 2000: Roaming through methodology. XXV. Outcome measures, surrogate outcomes, and intermediate measures Nederlands Tijdschrift Voor Geneeskunde 144(41): 1949-1952
Menard, H.A.; Mathieu, J.P.; de Medicis, R.; Lussier, A. 1979: Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results? Journal of Rheumatology 6(2): 156-162
Williams, R.C.; Malone, C.C.; Casali, P. 1992: Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. a possible mechanism for the in vivo generation of rheumatoid factors Journal of Immunology 149(5): 1817-1824
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Gibofsky, A.; Cannon, G.W.; Harrison, D.J.; Joseph, G.J.; Bitman, B.; Chaudhari, S.; Collier, D.H. 2015: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2) Clinical and Experimental Rheumatology 33(3): 297-301
Saltman, D. 1991: Critical reading and appraisal Australian Family Physician 20(9): 1307-1311
Berhan, Y.; Dwivedi, A.D. 2007: Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction Ethiopian Medical Journal 45(3): 235-242
Van Riezen, H.; Rigter, H.; Greven, H.M. 1977: Critical appraisal of peptide pharmacology Advances in Biochemical Psychopharmacology 17: 11-27
Owen, P.; Patel, N.B. 1994: A critical appraisal of fetal surveillance European Journal of Obstetrics-Gynecology and Reproductive Biology 57(2): 133-134
Ziegler, L.; Joffe, C.; Hay, N. 2002: A critical appraisal team for nurses Nursing Times 98(30): 39-40
Meuleman, J. 1987: Beliefs about osteoporosis. a critical appraisal Archives of Internal Medicine 147(4): 762-765